Center Laboratories, Inc. (TPEX:4123)
38.85
+1.25 (3.32%)
Aug 22, 2025, 2:32 PM CST
Center Laboratories Revenue
Center Laboratories had revenue of 378.71M TWD in the quarter ending June 30, 2025, a decrease of -8.40%. This brings the company's revenue in the last twelve months to 1.60B, up 4.93% year-over-year. In the year 2024, Center Laboratories had annual revenue of 1.62B with 16.06% growth.
Revenue (ttm)
1.60B
Revenue Growth
+4.93%
P/S Ratio
17.31
Revenue / Employee
n/a
Employees
n/a
Market Cap
27.67B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.62B | 223.86M | 16.06% |
Dec 31, 2023 | 1.39B | 626.29M | 81.58% |
Dec 31, 2022 | 767.72M | 267.62M | 53.51% |
Dec 31, 2021 | 500.11M | -216.94M | -30.25% |
Dec 31, 2020 | 717.05M | -720.63M | -50.12% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Caliway Biopharmaceuticals | 44.83M |
PharmaEssentia | 12.63B |
Bora Pharmaceuticals Co., LTD. | 21.32B |
Lotus Pharmaceutical | 19.12B |
Lumosa Therapeutics | 37.25M |
Oneness Biotech | 112.57M |
Polaris Group | 87.67M |
Pegavision | 6.67B |